Bit Origin
BTOG
Argo Blockchain
ARBK
Bit Digital
BTBT
Ebang International
EBON
MARA Holdings
MARA
US Stock MarketDetailed Quotes
ICCM Icecure Medical
- 1.300
- -0.030-2.26%
Trading Mar 4 14:26 ET
73.53MMarket Cap-4.64P/E (TTM)
1.310High1.260Low250.07KVolume1.290Open1.330Pre Close322.34KTurnover0.86%Turnover RatioLossP/E (Static)56.57MShares1.66052wk High7.30P/B37.84MFloat Cap0.48052wk Low--Dividend TTM29.11MShs Float16.000Historical High--Div YieldTTM3.76%Amplitude0.480Historical Low1.289Avg Price1Lot Size
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Icecure Medical Stock Forum
Can IceCure's New Cryoablation System Capture the $174B Minimally Invasive Surgery Market?
Application covering a wide range of indications is in line with trends in de-escalation of surgery and growth in minimally invasive cryoablation procedures, pointing to strong potential for increasing demand
CAESAREA, Israel, February 24, 2025 – IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure”, “IceCure Medical” or the “Company”), developer of minimally-...
IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision
Tuesday, 4th February at 8:30 am
Two independent studies of ProSense® cryoablation in breast cancer were presented, one of which won the Highest Scoring Abstract Award in its category
Hands-on ProSense® training featured during the S...
IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China
Monday, 27th January at 8:30 am
Seeks to expand regulatory approval in China where IceSense3 has already been approved
CAESAREA, Israel, Jan. 27, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, t...
IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America
Monday, 13th January at 7:00 am
Increase in sales of ProSense®, based on preliminary unaudited results, demonstrate growing adoption of ProSense® cryoablation for breast tumors.
FDA decision on market authorization of ProSense® for early-stage breast cancer is expected in the first quarter of 2025.
FDA Advisory Panel voted in favor of ProSense®'...
Patents and compliance regained....
this should be moving. 🤷
IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule
Monday, 6th January at 8:30 am
CAESAREA, Israel, Jan. 6, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it has received a notification letter from Nasdaq Stock Market LLC...
No comment yet